U.S. Markets open in 7 hrs 41 mins

Five Prime Therapeutics, Inc. (FPRX)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
29.85+0.84 (+2.90%)
At close: 4:00PM EDT
People also watch
MGNXXLRNEPZMENTAOMED
Full screen
Previous Close29.01
Open29.25
Bid0.00 x
Ask0.00 x
Day's Range29.23 - 30.46
52 Week Range26.65 - 60.98
Volume222,423
Avg. Volume288,269
Market Cap859.26M
Beta4.85
PE Ratio (TTM)-9.45
EPS (TTM)-3.16
Earnings DateAug 2, 2017 - Aug 7, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est61.07
Trade prices are not sourced from all markets
  • Capital Cube19 days ago

    Five Prime Therapeutics, Inc. – Value Analysis (NASDAQ:FPRX) : July 4, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Five Prime Therapeutics, Inc. a score of 25. Our analysis is based on comparing Five Prime Therapeutics, Inc. with the following peers – Pfizer Inc., GlaxoSmithKline plc Sponsored ADR, Johnson & Johnson, ArQule, Inc., Bristol-Myers Squibb Company, Lexicon Pharmaceuticals, Inc., Eli Lilly and Company, Regeneron Pharmaceuticals, Inc. ... Read more (Read more...)

  • Five Prime Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : FPRX-US : July 3, 2017
    Capital Cube21 days ago

    Five Prime Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : FPRX-US : July 3, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Five Prime Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • MarketWatchlast month

    Five Prime Therapeutics founder, CEO to step down

    Biotech company Five Prime Therapeutics, Inc. , said late Wednesday founder and Chief Executive Lewis T. "Rusty" Williams plans leave his post and become executive chairman of the board by next ...